A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route

Name: A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route
Creator: ClinicalTrials.gov
Published: 2026-07-12T01:58:48+08:00

DataMed2026-07-12 收录

药物生物利用度

药代动力学

数据链接：

https://datamed.org/dataset/f516a440-c19f-4877-b94a-331efcb27134 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to determine the bioavailability of nanoparticulate OZ439 delivered to the proximal small bowel (PSB) via the Enterion capsule relative to oral OZ439 suspension (current "powder in bottle" [PIB]) and oral nanoparticulate OZ439. The study will also characterise the plasma concentration time profile of OZ439 when delivered via Enterion capsule to the PSB in comparison with OZ439 PIB formulation delivered orally and nanoparticulate OZ439 delivered orally Safety and tolerability of OZ439 formulations will be determined following delivery to the PSB and administered orally

提供机构：

ClinicalTrials.gov

A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route

资源简介：

相关数据集